TABLE 1.
Clinical characteristics of NAFLD subjects examined for tissue NAMPT expression.
| Case | Fibrosis stage | NAS (1–8) | Age | Gender | BMI | Diabetes | Ethnicity |
|---|---|---|---|---|---|---|---|
| 1 | Stage 0 | 3 | 17 | M | 38.5 | No | Caucasian |
| 2 | Stage 1a | 4 | 32 | F | 35.1 | No | Hispanic |
| 3 | Stage 2 | 6 | 55 | M | 30.2 | Type 2 | Hispanic |
| 4 | Stage 3 | 5 | 46 | M | 33.4 | Type 2 | Caucasian |
| 5 | Stage 4 | 7 | 61 | F | 28.6 | Type 2 | Caucasian |